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Abstract 
There is currently increasing interest internationally in deploying robotic applications to SARS-CoV-2 
testing, as these can help to reduce risk of transmission of the virus to healthcare staff and patients.  
We provide an overview of key recent developments in this area. We argue that, although there is 
some potential for deploying robots to help with SARS-CoV-2 testing, the potential of patient-facing 
applications is likely to be limited. This is due to the high costs associated with patient-facing 
functionality, and risks of potentially adverse impacts on healthcare staff work practices and patient 
interactions.  
In contrast, back-end lab–based robots dealing with sample extraction and amplification, that 
effectively integrate with established processes, software and interfaces to process samples, are much 
more likely to result in safety and efficiency gains. Consideration should therefore be given to 
deploying these at scale.  
Introduction 
Testing is crucial to identify, curb spread and contain SARS-CoV-2. Testing capacity will therefore need 
to increase very substantially for the foreseeable future [1]. Robotic testing technologies may help to 
increase testing capacity and also minimise the risk of nosocomial transmission. There are currently 
two ways of testing for COVID-19: virological tests and serological tests. Virological methods work with 
genetic material obtained from nasal and/or throat or saliva swabs and commonly use Reverse 
Transcription Polymerase Chain Reaction (RT-PCR) technology to covert RNA to DNA. They detect the 
presence of SARS-CoV-2. Serological tests use saliva, whole blood, serum or plasma to look for 
antibodies. Various new testing methods that are variants of these two approaches are currently in 
development [2-6].  
However, despite a general recognition that testing for SARS-CoV-2 is a key international priority, 
there is currently a lack of testing capacity contributing to the inadequate numbers of tests being 
undertaken [7]. In addition, existing testing procedures can endanger healthcare staff and laboratory 
technicians (i.e. those who have to handle blood samples and swabs). We here provide an overview 
of key recent developments in robotic testing for SARS-CoV-2, which can help to reduce exposure to 
healthcare and technical staff. 
Overview of current developments in deploying robots for SARS-CoV-2 testing 
Robots for SARS-CoV-2 testing procedures can be either patient-facing (e.g. collecting nasal swabs and 
thereby reducing exposure of those collecting swabs) or non-patient facing (e.g. liquid handling 
machines that reduce exposure for laboratory technicians) (see Figure 1).  
Figure 1: Types of robots used for SARS-CoV-2 testing procedures 
To date, patient-facing testing robots have been mainly experimental, deployed as pilots and in limited 
settings. Examples include remote-controlled robots taking throat swabs that have been used in parts 
of China [8], a robotic arm handing out test tubes to drivers in cars for SARS-CoV-2 testing [9], and a 
3D-printed robotic arm taking throat swabs developed in Denmark [10]. Such robots are expensive 
(the Chinese robot costs ~£62,000), can only do a limited number of activities on one sample at a time 
(and therefore do not greatly increase the overall number of tests carried out). They can also worry 
patients due to a lack of personal contact [8]. Previous research has further found that patient-facing 
robotic applications can have unintended consequences resulting from adverse impacts on healthcare 
professional work practices, and on patient satisfaction [11,12]. For example, frail elderly and isolated 
patients depend on face-to-face contact as a source of emotional support. Attempts at making these 
applications more human-like may only partly address this issue, as robots that look too human-like 
can be perceived as threatening [13,14]. Patient-facing robots may, however, play a role in high-risk 
settings where infection control needs to be prioritised. They cannot replace face-to-face interactions 
that are required to provide high quality and safe care for the majority of patients.  
Non patient-facing testing robots including liquid handlers, especially those that do not involve 
contact dispensing, are more promising. These robots can move liquids using magnetic plates, 
aspirate, dispense or transport liquid samples (sometimes using pipettes), and in some cases interpret 
biological or chemical events (e.g. detect if a virus is present). This reduces exposure for laboratory 
technicians who have to have to handle blood samples and swabs, and interface with these machines 
for sample preparation. Many laboratories already utilise some degree of automation, and this 
mitigates risks of adverse impact on existing work practices of healthcare staff.  
Automated testing robots also have a high throughput and speed to tackle the large volumes of tests 
required during SARS-CoV-2 and in the “new normal”, as they can carry out numerous tests 
simultaneously [15]. For example, the Spanish Ministry of Health has recently commissioned four 
COVID-19 testing robots that will be able to carry out 80,000 tests a day [16]. Similarly, a newly 
established COVID-19 testing lab at Berkeley’s Innovative Genomics Institute (IGI) uses a robotic liquid 
handler machine that uses pipetting to test up to 3000 cases a day [17]. Another example is a Danish 
pipetting robot that automates the sample preparation process and was originally used for testing for 
salmonella before being repurposed to test for SARS-CoV-2 [18]. 
However, the functionality of these machines varies. Some RT-PCR liquid handlers only help up to 
extraction and addition of samples for PCR/RT-PCR, whilst others also transfer the material to a 
thermal cycler where PCR/RT-PCR happens (i.e. extraction, and amplification). Clearly, a closed-loop 
process (where technicians input a sample and the machine prepares samples and tests) is preferable 
as it minimises human contact with samples (including testing for multiple viruses). 
Another potential issue is the interfacing with existing software and associated communication of 
results. Some automated testing robots do not allow automatic downloading of results from the robot 
to the main laboratory computer, which then renders the whole process impractical as the large 
number of results generated has to be manually entered by technicians. This may also introduce the 
risk of transcription errors, which may in turn have adverse consequences for patient care [19]. 
Additional integration software can help to address this issue, but adds to the overall cost (in relation 
to both acquisition and maintenance) and may require additional programming.  
Conclusions 
Overall, there is a lack of empirical evidence on patient-facing virological/serological testing robots, 
and even if there was, these technologies would be unlikely to tackle pressing issues around scaling 
of testing capability. Testing robots in laboratories, however, have the potential to bring significant 
rapid benefits at low cost as these technologies can fulfil multiple purposes (e.g. handling other types 
of liquids). Moreover, they already exist in many laboratories and can therefore be readily repurposed 
to respond to COVID-19 (although this has to be done by the manufacturer). Most useful are likely to 
be non patient-facing testing robots that tackle the whole extraction and amplification cycle, as this 
will eliminate the need for transfer of material for the amplification stage and thereby minimise the 
risk of unintended consequences.  
Where there are established processes (e.g. back-end lab–based robots tackling extraction and 
amplification) and where these interface effectively with existing software to process the results, 
these should be scaled up. In parallel, there is a need to stimulate research and innovation initiatives 
to explore the feasibility of developing a scalable front-end testing robot for high-risk settings (e.g. 
infectious disease wards).  
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